IL13 and Alzheimer disease: Moreover, the expression of FLAP mRNA displayed a significantly higher expression in non-stimulated (2,3-fold), in histamine (5,3-fold), in IL-4 (2,5-fold) and in IL-13 (10,7-fold) stimulated mast cells from AD patients as compared to cells from HVs (Fig. 1B).